SCHEMBL9375592

SCHEMBL9375592

CN1CCc2ccccc2C1(C)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.41
EBP Q15125 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
DRD2 P14416 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR2B P41595 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5245017 0.87 SIGMAR1 (0.46) SIGMAR1EBP
Hydrochloric Acid SCHEMBL9374939 0.81 OPRM1 (0.43) SIGMAR1EBPALDH1A1MAPK1TP53
SCHEMBL9374898 0.80 SIGMAR1 (0.48) SIGMAR1ALDH1A1MAPK1TP53CYP1A2
Hydrochloric Acid SCHEMBL9376392 0.79 SIGMAR1 (0.51) SIGMAR1MAPK1TP53CYP1A2CYP3A4
SCHEMBL7654995 0.78 DRD2 (0.45) SIGMAR1EBPALDH1A1MAPK1SMN1; SMN2
SCHEMBL9376129 0.77 SIGMAR1 (0.47) SIGMAR1ADRA2A
Hydrochloric Acid SCHEMBL9374650 0.77 CHRM2 (0.49) SIGMAR1EBPMAPK1CHRM2ADRA2A
Hydrochloric Acid SCHEMBL9380497 0.75 SIGMAR1 (0.41) SIGMAR1ALDH1A1MAPK1SMN1; SMN2CHRM2
SCHEMBL9374100 0.75 SIGMAR1 (0.50) SIGMAR1ALDH1A1MAPK1TP53CYP1A2
SCHEMBL9380415 0.75 RAB9A (0.41) SIGMAR1ALDH1A1MAPK1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102256947-A Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators GRUENENTHAL GMBH 2011-11-23 CN disclosed
EP-0336228-B1 Tetrahydroisoquinolines and tetrahydrobenzazepines and a process for the preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-09 EP disclosed
US-5059608-A Anticonvulsants, antiischemic agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-22 US disclosed
CN-1036758-A Bicyclic amine compound and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1989-11-01 CN disclosed
EP-0336228-A1 Tetrahydroisoquinolines and tetrahydrobenzazepines and a process for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-10-11 EP disclosed